Does Ozempic affect menstrual cycle patterns in women taking this medication? Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus. Whilst menstrual changes are not listed as a direct adverse effect in the Summary of Product Characteristics, some women report cycle alterations after starting treatment. The relationship appears indirect: significant weight loss induced by semaglutide can disrupt the hypothalamic-pituitary-ovarian axis, affecting reproductive hormones. Women may experience irregular periods, changes in bleeding patterns, or temporary amenorrhoea. This is particularly relevant for those with polycystic ovary syndrome, where weight reduction may restore ovulatory function. Understanding these potential changes helps women make informed decisions about their diabetes management.

Does Ozempic Affect Your Menstrual Cycle?

Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK specifically for the treatment of type 2 diabetes mellitus. Menstrual cycle changes are not listed as a direct adverse effect in the Summary of Product Characteristics (SmPC) for Ozempic as approved by the Medicines and Healthcare products Regulatory Agency (MHRA). However, some post-marketing reports suggest alterations to menstrual cycles after starting this medication.

The relationship between Ozempic and menstrual changes is likely indirect rather than direct. Semaglutide works by mimicking the incretin hormone GLP-1, which enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. These mechanisms lead to improved glycaemic control and, commonly, significant weight loss. It is this weight loss—rather than the drug itself—that appears to be the primary driver of menstrual cycle changes in many women.

Weight fluctuations can profoundly affect reproductive hormones. Adipose tissue plays an active role in oestrogen production and metabolism, and rapid weight loss can disrupt the hypothalamic-pituitary-ovarian axis. Women may experience irregular periods, heavier or lighter bleeding, changes in cycle length, or even temporary amenorrhoea (absence of periods). These changes are particularly notable in women with pre-existing hormonal conditions such as polycystic ovary syndrome (PCOS), where weight loss can actually restore ovulatory function.

There is no official link established between semaglutide and direct hormonal disruption of the menstrual cycle. However, the metabolic and weight changes it induces can create a cascade of hormonal adjustments that manifest as menstrual irregularities. If you are experiencing unexpected period changes whilst taking Ozempic, it is important to discuss these with your GP to rule out other causes and ensure appropriate monitoring. You can also report suspected side effects via the MHRA Yellow Card scheme.

Weight Loss, PCOS and Menstrual Changes on Ozempic

The connection between weight loss and menstrual cycle regulation is particularly significant for women with polycystic ovary syndrome (PCOS), a common endocrine disorder affecting approximately 10% of women of reproductive age in the UK. PCOS is characterised by insulin resistance, hyperandrogenism (elevated male hormones), and irregular or absent ovulation, often leading to infrequent or absent periods.

Weight loss of just 5–10% of body weight can significantly improve PCOS symptoms, including menstrual regularity. According to NICE Clinical Knowledge Summary (CKS) on PCOS, lifestyle modification with weight management is a first-line intervention for overweight women with PCOS. When women with PCOS take Ozempic for diabetes management, the resulting weight reduction can restore ovulatory cycles. This means women who previously had infrequent periods may suddenly experience more regular menstruation, which, whilst positive for fertility and metabolic health, can be unexpected.

Conversely, women without PCOS who lose weight rapidly on semaglutide may experience the opposite effect: disrupted cycles or temporary amenorrhoea. Rapid weight loss can signal energy deficiency to the hypothalamus, suppressing gonadotropin-releasing hormone (GnRH) and subsequently reducing luteinising hormone (LH) and follicle-stimulating hormone (FSH). This protective mechanism can temporarily halt ovulation and menstruation.

Changes in body composition also affect oestrogen levels. Adipose tissue converts androgens to oestrogens via the enzyme aromatase. As fat mass decreases, circulating oestrogen levels may drop, potentially leading to lighter periods or spotting. Additionally, improved insulin sensitivity—a beneficial effect of both semaglutide and weight loss—can alter the hormonal milieu, further influencing menstrual patterns.

It is important to note that restoration of fertility may occur unexpectedly in women with PCOS or obesity-related anovulation who begin losing weight on Ozempic. According to the Ozempic SmPC, women of childbearing potential should use effective contraception, as semaglutide is not recommended during pregnancy and should be discontinued at least two months before planned conception.

When to Speak to Your GP About Period Changes

Whilst some menstrual changes during weight loss on Ozempic may be expected, certain symptoms warrant prompt medical evaluation. You should contact your GP if you experience any of the following:

• Heavy menstrual bleeding (HMB): soaking through a pad or tampon every hour for several consecutive hours, passing clots larger than a 50p coin, or bleeding lasting longer than seven days

• Postcoital or intermenstrual bleeding: any bleeding between periods or after sexual intercourse requires investigation to exclude structural or pathological causes

• Complete absence of periods (amenorrhoea) for three months or more: particularly if you previously had regular cycles and pregnancy has been excluded

• Severe pelvic pain: especially if accompanied by fever, unusual discharge, or pain during intercourse, which could indicate infection or other gynaecological conditions

• Sudden onset of very irregular cycles: if your previously predictable periods become highly erratic without explanation

Your GP will likely perform a thorough assessment, including a detailed menstrual history, medication review, and examination if appropriate. Initial investigations may include a pregnancy test (as unexpected ovulation can occur with weight loss), full blood count to assess for anaemia, thyroid function tests, and possibly prolactin levels if amenorrhoea is present. Depending on your age, symptoms, and risk factors, further investigations such as pelvic ultrasound, hormonal profiling (including FSH, LH, oestradiol, and androgens), or referral to gynaecology may be warranted.

It is particularly important to seek advice if you have risk factors for endometrial pathology, including age over 45, obesity, PCOS, diabetes, or a family history of gynaecological cancers. NICE guidance (NG12) recommends an urgent suspected cancer referral (within two weeks) for postmenopausal bleeding in women aged 55 and over. Any postmenopausal bleeding requires urgent assessment regardless of age.

Keep a menstrual diary documenting cycle length, duration of bleeding, and heaviness (number of sanitary products used). This information is invaluable for your GP in determining whether your symptoms require investigation or are likely related to the metabolic changes induced by Ozempic and weight loss.

Managing Menstrual Side Effects While Taking Ozempic

If you are experiencing menstrual changes whilst taking Ozempic, several strategies can help manage symptoms whilst continuing treatment, provided serious pathology has been excluded by your healthcare provider.

For irregular cycles or spotting, maintaining a consistent routine can help. Ensure adequate nutrition despite reduced appetite—semaglutide significantly decreases hunger, but severe caloric restriction can worsen menstrual irregularities. Aim for a balanced diet with sufficient protein, healthy fats, and micronutrients, particularly iron if you experience heavier bleeding. The rate of weight loss may influence menstrual disruption; a more gradual reduction (0.5–1 kg per week) may be better tolerated hormonally than rapid loss.

If periods become heavier, discuss with your GP whether iron supplementation is appropriate, particularly if you develop symptoms of anaemia such as fatigue, breathlessness, or pallor. Tranexamic acid is available from pharmacies for women aged 18-45 with regular heavy periods and can reduce menstrual blood loss by up to 50%. However, it has contraindications including history of blood clots, and should not be used with combined hormonal contraceptives. Always consult a pharmacist or GP before use. For ongoing heavy menstrual bleeding, your GP may consider hormonal treatments such as the levonorgestrel intrauterine system (Mirena coil), which according to NICE guidance (NG88) can reduce menstrual bleeding by 71-95% and is also an effective contraceptive.

For women with PCOS experiencing return of regular cycles, this is generally a positive sign of metabolic improvement. However, if fertility is not desired, ensure reliable contraception is in place, as ovulation may resume unexpectedly. According to the Ozempic SmPC, injectable semaglutide does not significantly affect the exposure of combined oral contraceptives. Discuss with your GP whether continuing Ozempic aligns with your long-term management plan for PCOS, alongside other interventions such as metformin for metabolic features (though this is an off-label use in PCOS in the UK).

Lifestyle measures can support hormonal balance during this transition. Regular moderate exercise, stress management techniques, and adequate sleep all contribute to hypothalamic-pituitary-ovarian axis regulation. Avoid excessive exercise, which can worsen menstrual irregularities in the context of weight loss.

Communication with your diabetes team is essential. If menstrual side effects are significantly affecting your quality of life, your prescriber may consider adjusting the dose of semaglutide or exploring alternative options. Never stop or adjust your medication without medical guidance, as this could affect your glycaemic control.

Finally, be patient with your body. Menstrual cycles often stabilise once weight loss plateaus and a new metabolic equilibrium is established. Most women find that irregular periods resolve within three to six months as their body adjusts to the new weight and hormonal environment. If you suspect your menstrual changes are a medication side effect, report this through the MHRA Yellow Card scheme.

Frequently Asked Questions